New asthma drug aims to slash severe attacks in teens and adults
NCT ID NCT06488755
First seen Apr 12, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This study tests an experimental drug called SIM0718 for people with eosinophilic asthma, a type often triggered by allergies. About 418 adults and teens aged 12–75 who still have symptoms despite standard inhalers will receive either SIM0718 or a placebo for one year. The main goal is to see if the drug reduces the number of severe asthma attacks and improves breathing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA; EOSINOPHILIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
China Japan Friendship Hospital
RECRUITINGBeijing, Beijing Municipality, 100000, China
Contact
Conditions
Explore the condition pages connected to this study.